GABAergic and inflammatory changes in the frontal cortex following neonatal PCP plus isolation rearing, as a dual-hit neurodevelopmental model for schizophrenia
Open Access
- 16 February 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (9) , 6968-6983
Abstract
The pathogenesis of schizophrenia begins in early neurodevelopment and leads to excitatory-inhibitory imbalance. It is therefore essential that preclinical models used to understand disease, select drug targets and evaluate novel therapeutics encompass similar neurochemical deficits. One approach to improved preclinical modelling incorporates dual-hit neurodevelopmental insults, like neonatal administration of phencyclidine (PCP, to disrupt development of glutamatergic circuitry) then post-weaning isolation (Iso, to mimic adolescent social stress). We recently showed that male Lister-hooded rats exposed to PCP-Iso exhibit reduced hippocampal expression of the GABA interneuron marker calbindin. The current study expanded on this by investigating changes to additional populations of GABAergic interneurons in frontal cortical and hippocampal tissue from the same animals (by immunohistochemistry) as well as levels of GABA itself (via ELISA). Because inflammatory changes are also implicated in schizophrenia, we performed additional immunohistochemical evaluations of Iba-1 positive microglia as well as ELISA analysis of IL-6 in the same brain regions. Single-hit isolation-reared and dual-hit PCP-Iso rats both showed reduced parvalbumin immunoreactivity in the prelimbic/infralimbic region of the frontal cortex. However, this was more widespread in PCP-Iso, extending to the medial/ventral and lateral/dorsolateral orbitofrontal cortices. Loss of GABAergic markers was accompanied by increased microglial activation in the medial/ventral orbitofrontal cortices of PCP-Iso, together with frontal cortical IL-6 elevations not seen following single-hit isolation rearing. These findings enhance the face validity of PCP-Iso, and we advocate the use of this preclinical model for future evaluation of novel therapeutics—especially those designed to normalise excitatory-inhibitory imbalance or reduce neuroinflammation.Keywords
This publication has 119 references indexed in Scilit:
- Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenicsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1999
- Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing BrainScience, 1999
- Schizophrenia and the parvalbumin-containing class of cortical local circuit neuronsAmerican Journal of Psychiatry, 1997
- Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenicsSchizophrenia Research, 1997
- Distribution of nonprincipal neurons in the rat hippocampus, with special reference to their dorsoventral differenceBrain Research, 1997
- Prefrontal Cortex and Working Memory for Spatial Response, Spatial Location, and Visual Object Information in the RatCerebral Cortex, 1996
- Gene Expression for Glutamic Acid Decarboxylase Is Reduced Without Loss of Neurons in Prefrontal Cortex of SchizophrenicsArchives of General Psychiatry, 1995
- Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortexBrain Research, 1994
- Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective PatientsArchives of General Psychiatry, 1991
- The dispositional kinetics of phencyclidine and itsN-ethylamine analogue in ratsEuropean Journal of Drug Metabolism and Pharmacokinetics, 1983